Scoop has an Ethical Paywall
Licence needed for work use Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Carmen Doran Wins Inspiring Women Leaders Category At The New Zealand International Business Awards

Carmen Doran, CEO of Auckland-based medicines company Helius Therapeutics, has been recognised in the Inspiring Women Leaders category at the New Zealand International Business Awards last night. Doran's leadership has been instrumental in driving the success of Helius Therapeutics, a company focused on medicinal cannabis research and development.

Under Doran's guidance, Helius Therapeutics has become New Zealand's largest licensed medicinal cannabis producer, with a bold vision to become a world leader in the research, development, and distribution of next-generation cannabinoid medicines.

The company has achieved significant milestones, including being the first in the industry to gain the GMP Licence to Manufacture Medicines in 2021 and the first company to provide NZ grown, NZ made products for Kiwi patients, building solid foundations for export success.

Helius Therapeutics is dedicated to improving the quality of life through the research and development of natural cannabis compounds, novel formulae, and delivery systems. The company has already made a significant impact on the local market, with industry-wide sales expected to nearly double this year to over 130,000 prescriptions based on growth rates.

Doran's leadership has also positioned Helius Therapeutics for international success utilising her international experience in pharmaceuticals and commitment to patient outcomes. The company plans to be the first medicinal cannabis company to start exporting finished medicinal cannabis products from New Zealand, targeting markets in Europe, South America, and Australia.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

This focus on export aligns with the company's mission to improve lives globally through the power of medicinal cannabis.

Carmen Doran's recognition at the New Zealand International Business Awards highlights her exceptional leadership and the growing success of Helius Therapeutics in the medicinal cannabis industry. As the company continues to innovate and expand, it is poised to make a significant impact on the global market, further solidifying New Zealand's reputation as a leader in the biotechnology sector.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.